Three independent discounted-cash-flow-style models value OptimizeRx Corporation Common Stock every trading day. 0 of 3 currently price OPRX above its market price.
| Free Cash Flow model | $7.41 |
| Excess Profit model | $-21.54 |
| Residual Earnings model | $-0.83 |
| Dividend Discount model | — |
| Piotroski F-Score | 8 / 9 |
| Return on invested capital | +6.0% |
| Net debt / EBITDA | 0.3× |
| Gross margin | +67.3% |
| Revenue CAGR | +20.6% |
| Cash conversion | 3.6× |
| Dividend yield | — |
| Buyback yield | -1.4% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open OPRX in StockKitty